Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

ICER says price of Amgen/Novartis’ Aimovig is OK – if used last-line

Recommends the drug should only be used in patients who have exhausted other prevention options

- PMLiVE

Is connecting internal and external the next critical step for integrated communications?

Many marcomms agencies have evolved from being single channel or audience specialists to offering a broader, integrated service. This is to achieve more meaningful programmes for clients, in order to...

- PMLiVE

Iontas gets UK backing for chronic pain antibody project

Receives just under £800,000 from the UK government

- PMLiVE

J&J moves quickly ahead with trials of myeloma CAR-T

Expects to start trials during the second half of this year

Abeona Therapeutics appoints new additions to board of directors

Stefano Buono and Richard Van Duyne join the biopharma

- PMLiVE

Prevail Therapeutics adds to its board of directors

Francois Nader joins the biotech

The true potential of mobile health tech

Are patients willing to adopt digital?

- PMLiVE

Patient outcomes in practice: delivering value that transforms lives

Over the next five years, the NHS needs to drive efficiencies of £22bn. Like all global healthcare systems, it faces the challenge of improving the health of larger and older...

EphMRA Annual Conference 2018

Visit us on stand number 20

Inizio

Live from Singapore: Full speed ahead – Unlock the full potential of your brand tracking

Thursday 28th June 16:00 SGT/ 16:00 CST / 17:00 JST

Inizio

Connected Patients – Adopting a patient-centric approach in emerging markets

The concept of patient centricity and putting the patient at the heart of care is being widely adopted by the healthcare industry – the general consensus being that it’s going...

Inizio

Combination therapies in oncology: The benefits of integrated insights

14 June 2018 11am EDT | 8am PDT | 4pm BST | 5pm CE

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links